Skip to main content
Sihuan Pharmaceutical Holdings Group Ltd. logo

Sihuan Pharmaceutical Holdings Group Ltd. — Investor Relations & Filings

Ticker · 460 ISIN · BMG8162K1137 LEI · 529900UD7C9N3AQO1V88 HKEX Manufacturing
Open in API
Filings indexed 962 across all filing types
Latest filing 2026-05-27 Transaction in Own Shar…
Country BM Bermuda
Listing HKEX 460

About Sihuan Pharmaceutical Holdings Group Ltd.

http://www.sihuanpharm.com

Sihuan Pharmaceutical Holdings Group Ltd. is an innovation-driven biopharmaceutical and medical aesthetic enterprise specializing in the research, development, manufacturing, and marketing of healthcare products. The company maintains a dual focus: a robust pharmaceutical segment and a rapidly expanding medical aesthetics business. Historically strong in the cardiovascular and cerebrovascular therapeutic areas, its pharmaceutical portfolio now spans five major categories, including anti-infectives, digestive system treatments, and metabolic drugs, alongside innovative biologics and generics. The medical aesthetics division offers a range of products such as dermal fillers, body sculpturing solutions, and optoelectronic devices. Sihuan is committed to leveraging specialized products and services to advance human health.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO THE SHARE AWARD SCHEME
Transaction in Own Shares Classification · 91% confidence The document is a voluntary announcement by Sihuan Pharmaceutical regarding the purchase of its own shares on market under its Share Award Scheme by the trustee. This is a report of the company (via trustee) buying back its own shares rather than a normal financing, management change, or dividend notice. It matches the definition for Transaction in Own Shares (POS).
2026-05-27 English
VOLUNTARY ANNOUNCEMENT SHARE REPURCHASE
Transaction in Own Shares Classification · 95% confidence The document is a corporate announcement detailing the company’s voluntary share repurchase under its general mandate, including number of shares repurchased, prices, total cost, and purposes of holding as treasury shares. This corresponds to a report of the company buying back its own shares. Therefore, it falls under “Transaction in Own Shares” (POS).
2026-05-18 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is a Hong Kong Stock Exchange Next Day Disclosure Return (Form FF305) detailing the issuer’s share repurchase (buyback) transactions and changes in treasury shares, pursuant to Main Board Rule 13.25A/GEM Rule 17.27A. This is a regulatory disclosure of the company’s own share transactions (buybacks and treasury share movements), matching the “Transaction in Own Shares” category.
2026-05-18 English
VOLUNTARY ANNOUNCEMENT SHARE REPURCHASE
Transaction in Own Shares Classification · 90% confidence The document is a Hong Kong Stock Exchange announcement detailing a voluntary share repurchase (10,000,000 shares repurchased under a repurchase mandate) including price, mandate reference, and purpose of holding as treasury shares. This clearly describes a transaction in the company’s own shares. According to the definitions, this is classified as POS (Transaction in Own Shares).
2026-05-13 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is a Hong Kong Exchange “Next Day Disclosure Return” (FF305) detailing changes in issued shares and treasury shares, specifically a company share repurchase (10,000,000 shares repurchased on‐market). It contains tables of opening/closing balances, repurchase prices, and confirmations by the issuer. This is a direct report of the company’s transaction in its own shares (share buyback) rather than an announcement of an external report. Therefore, it should be classified as a Transaction in Own Shares (POS).
2026-05-13 English
VOLUNTARY ANNOUNCEMENT-COMPLETION OF THE H SHARE FULL CIRCULATION BY XUANZHU BIOPHARM
Share Issue/Capital Change Classification · 87% confidence The document is a voluntary announcement about the completion of the conversion and listing of unlisted shares into H shares for a subsidiary, detailing the change in share capital structure. It does not contain financial results or constitute a full report, but rather an announcement of a capital change. This fits the definition of a Share Issue/Capital Change announcement (SHA).
2026-05-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.